In brief (TL;DR)
Hair loss in women is common and usually has one of two main causes: hereditary hair loss (female androgenetic alopecia), where the part gradually widens, or diffuse shedding following a trigger such as infection, crash dieting, surgery, or iron deficiency (telogen effluvium).
The only treatment with a strong guideline recommendation for the hereditary type is minoxidil. The European S3 guideline expressly provides no recommendation for dietary supplements.
Nutrients still play a role – but in a targeted manner: Low ferritin and vitamin D deficiency occur significantly more often in women with hair loss. Therefore, a blood test first, followed by targeted correction, makes sense. Based on current research, biotin is not a hair growth supplement if there is no deficiency.
Important medical notice
This article provides health information and does not replace examination by a dermatologist, gynecologist, or general practitioner. Sudden, patchy, or very severe hair loss, hair loss accompanied by itching, redness or scaling, as well as accompanying symptoms like cycle irregularities, acne, or increased body hair must be clarified by a doctor.
Prescription therapies such as oral minoxidil or antiandrogens are strictly a medical decision. Dietary supplements are not drugs and do not treat hair loss.
Hair loss in women: How common is it really?
Visibly thinning hair affects nearly one in three adult women – and the proportion increases steadily with age. This is the result of one of the few population-based studies in which women were not only surveyed but actually examined dermatologically.
Researchers Gan and Prof. Rodney Sinclair examined 193 women in Maryborough, Australia, and classified the hair patterns using a standardized scale. Among those aged 20–29, 12.3% showed signs of hereditary hair loss, while among women over 80, the figure was 57.4%. The age-standardized prevalence was 32.2%, with 10.5% showing moderate to severe extent.
Two things can be deduced from this. First, thinning hair in women is not a marginal phenomenon that shouldn't be discussed. Second, it affects even young women – a thinning part in your mid-twenties is not automatically a sign of a nutrient deficiency.
Genetic or diffuse: What type of hair loss do I have?
In women, two forms are at the forefront: hereditary hair loss, which manifests over years at the crown, and telogen effluvium, where hair falls out suddenly and distributed over the entire head. Distinguishing between them determines what makes sense.
Hereditary hair loss (female androgenetic alopecia)
A widening center part is typical, while the front hairline usually remains intact. Over many cycles, hair follicles shrink and produce finer, shorter hairs. Genetics and the hormonal sensitivity of the follicles play a role, but a measurably elevated androgen level is by no means present in all those affected.
Telogen effluvium: sudden, diffuse shedding
Here, a larger proportion of hair simultaneously shifts into the resting phase and falls out a few weeks later. The tricky part is the time delay: the trigger is usually about three months in the past.
In the medical reference work StatPearls, published via the US National Library of Medicine (NCBI Bookshelf), authors Hughes, Syed, and Saleh identify typical triggers as febrile infections, surgery, severe injuries, the postpartum period, stopping estrogen-containing preparations, crash diets, insufficient protein, and iron deficiency. According to this, the interval between the trigger and hair loss is usually about three months, but can vary between one and six months.
→ Source: Hughes EC, Syed HA, Saleh D – Telogen Effluvium, StatPearls, NCBI Bookshelf (as of 2024)
The good news with acute telogen effluvium: it is generally temporary and lasts less than six months. After birth, the progression is so typical that we have dedicated a separate article to it: Postpartum hair loss.
| Feature | Hereditary hair loss | Telogen effluvium |
|---|---|---|
| Onset | Gradual over years | Relatively sudden, often about three months after a trigger |
| Pattern | Widening part on the crown, hairline usually preserved | Distributed over the whole head, much hair in brushes and drains |
| Hair quality | Hair becomes finer and shorter | Shed hair is usually normal thickness, with a small, pale root end |
| Progression | Progressive without treatment | Acute usually under six months; chronic progression possible |
| First step | Dermatological diagnosis, guideline-based treatment | Find trigger, check blood values, patience |
Both forms can occur simultaneously. The table does not replace a scalp examination (trichoscopy) by a dermatologist.
Which blood values are useful for hair loss
For diffuse hair loss, three laboratory areas in particular make sense: the thyroid (TSH), iron status with ferritin, and a blood count. These values cover the most frequent treatable causes.
It is precisely this basic diagnostics that Hughes, Syed, and Saleh recommend in StatPearls for telogen effluvium: TSH to exclude hypothyroidism, as well as blood count, serum iron, transferrin saturation, and ferritin to clarify iron deficiency.
→ Source: StatPearls – Telogen Effluvium (Evaluation)
Anyone who also notices irregular cycles, acne, or increased facial hair should address this with their doctor – this combination can indicate androgen excess, for example in the context of PCOS. For known or suspected autoimmune thyroiditis, it is worth looking at our article on Hashimoto in women.
VEYT Lab Tip: Pause biotin before the blood test
High-dose biotin can distort certain laboratory procedures – including thyroid and heart values. Tell your practice if you are taking biotin. Details on this in the section on biotin below.
Ferritin and iron: The best-supported nutrient connection
Women with hair loss have, on average, significantly lower ferritin values than women without hair loss. Of all nutrients, this connection is the most consistently documented – anemia does not need to be present for this.
In a 2022 meta-analysis, the research team led by Treister-Goltzman, Yarza, and Peleg evaluated 36 studies with over 10,000 participants. Women with non-scarring alopecia had significantly lower ferritin values, especially before menopause. Depending on the threshold, 21% (threshold 10–15) to 59% (threshold 30–40) showed a low ferritin level, whereas true iron deficiency anemia was present in only 8%.
The limitations of this data are important: the included studies were very heterogeneous and came predominantly from specialized clinics. Furthermore, a correlation does not prove that iron stops hair loss. The sensible consequence is therefore: Have ferritin measured – and only supplement in a targeted manner if a deficiency is confirmed. Taking iron "on suspicion" without a deficiency is not advisable, because the body can hardly excrete excess iron.
We explain in detail how much iron women need daily and what signs of deficiency are typical in Iron for women: requirements, dosage, and signs of deficiency. If a doctor recommends supplementation, VEYT Iron Vitality Core with iron bisglycinate is a potential option – to correct a deficiency, not as a hair growth product.
Vitamin D: Strong connection, but no treatment studies
Vitamin D deficiency is noticeably common in women with hereditary hair loss. Whether vitamin D administration improves hair condition, however, has not been proven for this group by randomized studies.
A team led by dermatologist Poonkiat Suchonwanit of Mahidol University in Thailand analyzed 81 studies with 15,339 affected individuals in Frontiers in Nutrition in 2024. In women with hereditary hair loss, the proportion with vitamin D deficiency was 50.38%. The chance of a deficiency was approximately five times higher compared to control subjects (odds ratio 5.24; 95% CI 1.50–18.33), and the mean vitamin D level was about 15.7 ng/ml lower. The authors therefore consider screening useful and call for studies on supplementation.
The very wide confidence interval shows how uncertain the estimate is. Furthermore, observational data cannot clarify whether a low level is a cause, a consequence, or merely an incidental finding – for instance, because women with hair loss may have different dietary habits or spend less time in the sun. In practical terms, this means: having your vitamin D level checked is reasonable, and correcting a deficiency is as well. However, this is not a treatment for hair loss. Information on how much vitamin D per day is sensible can be found in Vitamin D3 dosage: How many IU per day make sense.
Biotin: Why the most famous hair vitamin is disappointing
According to current studies, biotin only helps in cases of a genuine biotin deficiency – and that is rare. For healthy women without a deficiency, there are no high-quality studies showing a benefit for hair growth.
In 2024, Yelich, Jenkins, Holt, and Miller systematically searched the literature in the Journal of Clinical and Aesthetic Dermatology. Only three studies met their quality criteria. The methodologically best one – a placebo-controlled double-blind study – found no difference in hair growth. The authors' conclusion: The benefit of biotin as a hair supplement is not supported by high-quality studies.
In addition, there is a practical risk: The US Food and Drug Administration (FDA) has warned since 2017, most recently updated in 2022, that biotin from dietary supplements can significantly distort certain laboratory tests. Particularly critical are falsely low troponin levels – the test used to detect a heart attack.
→ Source: U.S. Food and Drug Administration – Biotin Interference with Troponin Lab Tests (2022)
You can find more on the biotin study situation for skin and nails in Biotin effect: What studies show regarding hair, skin, and nails.
Minoxidil: The only treatment with a strong guideline recommendation
For androgenetic (hereditary) hair loss in women, topical minoxidil is the treatment with the best evidence. It is the only therapy explicitly recommended for women by the European S3 guideline.
The Cochrane review by Esther van Zuuren, Zbys Fedorowicz, and Jan Schoones (2016) included 47 studies with 5,290 women. In six studies, about twice as many women achieved moderate regrowth with minoxidil compared to placebo. In four studies, the 5% concentration provided no advantage over 2%. Side effects were mostly mild, such as itching or irritation of the scalp.
The European S3 guideline for androgenetic alopecia, on which dermatologist Prof. Ulrike Blume-Peytavi of the Charité participated as an author, recommends that women aged 18 and older use 2% minoxidil solution (1 ml twice daily) or 5% foam (half a capful once daily). It makes no recommendation for dietary supplements or platelet-rich plasma (PRP) due to insufficient data.
Important for expectations: The guideline formulates the goal as an improvement in hair appearance or the prevention of progression – not a cure. How long and in what form minoxidil is used should be discussed with a dermatologist.
Low-dose oral minoxidil: the current trend
Minoxidil in very low-dose tablet form is increasingly being used in dermatology practices, but it is not approved for hair loss in Germany. Prescription is off-label and belongs in the hands of a dermatologist.
In a randomized study, Brazilian dermatologist Dr. Paulo Müller Ramos and Australian hair specialist Prof. Rodney Sinclair compared 1 mg of oral minoxidil with 5% topical minoxidil in 52 women. After six months, the results were comparable; the tablet was thus not clearly superior, but it is an alternative for women who cannot manage with the solution.
Regarding safety, Dr. Sergio Vañó-Galván from the Ramón y Cajal University Hospital in Madrid and his colleagues evaluated data from 1,404 patients, two-thirds of whom were women. The most common side effect was increased hair growth on the face or body (15.1%), followed by lightheadedness (1.7%), fluid retention (1.3%), and heart palpitations (0.9%). Only 1.7% discontinued the treatment.
→ Source: Vañó-Galván S et al. – Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients, J Am Acad Dermatol (2021) · Deutsche Apotheker Zeitung – Oral minoxidil against hair loss: use so far off-label (2025)
Minoxidil was originally developed as a blood pressure medication. Anyone with cardiovascular disease, who takes blood pressure medication, or who is pregnant or breastfeeding must clarify this with a doctor in advance – self-treatment with pills from the internet is not a good idea.
Antiandrogens: When spironolactone or cyproterone acetate are considered
Antiandrogens are an option for women who have clinical or laboratory signs of androgen excess. The evidence is significantly weaker than for minoxidil.
The S3 guideline only rates cyproterone acetate as "may be considered" for women with hyperandrogenism and advises against finasteride in postmenopausal women. Spironolactone is used internationally for hair loss. A meta-analysis by Majed Aleissa (2023) found improvement in 56.6% of treated women, and 65.8% when combined with other therapies. The meta-analysis included randomized and observational studies whose results were very inconsistent.
→ Sources: S3 guideline androgenetic alopecia (2018) · Aleissa M – Oral Spironolactone in Female Pattern Hair Loss: Systematic Review and Meta-Analysis, Cureus (2023)
Rosemary oil, PRP, and laser: What studies leave open
Rosemary oil is the most popular "natural" tip for hair loss – however, the underlying study was conducted exclusively on men. Comparable data for women is missing.
In the frequently cited study by Yunes Panahi and colleagues (2015), 100 men with hereditary hair loss used either rosemary oil or 2% minoxidil for six months. After three months, neither group showed a significant change; after six months, both showed a comparable increase in hair count. Scalp itching occurred in both groups, more frequently with rosemary oil.
A single small study with men, compared to the weaker 2% concentration, is not enough to label rosemary oil as equivalent to minoxidil for women. The S3 guideline only suggests low-level laser therapy as a supplementary option; it makes no recommendation for PRP. The Cochrane review found no advantage over sham treatment for laser combs in two studies.
Evidence Map: What plays a role in female hair loss
| Approach | For what | Evidence level | What does not follow from this |
|---|---|---|---|
| Topical Minoxidil | Hereditary hair loss | Cochrane Review, strong S3 recommendation | Goal: Improvement or stop of progression, not a cure |
| Oral minoxidil (low-dose) | Hereditary hair loss | Small RCTs, large safety analysis | No approval for hair loss, do not self-experiment |
| Antiandrogens | Hair loss with androgen signs | Weak to medium evidence, heterogeneous | Not suitable for every woman |
| Iron / Ferritin | Proven iron deficiency | Meta-analysis: lower ferritin in hair loss | No benefit without deficiency; avoid overdosing |
| Vitamin D | Proven deficiency | Strong association, no therapeutic RCTs in women | Not a hair loss treatment |
| Biotin | Rare genuine biotin deficiency | No proven benefit for healthy individuals | Can distort lab results |
| Rosemary oil | Hereditary hair loss | One RCT, men only | No proven substitute for minoxidil in women |
| PRP / Nutritional supplements in general | Hereditary hair loss | S3 guideline: no recommendation possible | Neither proven nor disproven |
This overview is an evidence-based classification and not an individual therapy recommendation.
The VEYT Hair Check: 5 steps in the right order
- Recognize patterns: Is the part slowly getting wider, or has there been a recent increase in hair loss all over? Photos of the part taken under the same lighting a few weeks apart help.
- Think back three months: Have there been any fevers, surgeries, births, diets, significant stress, or discontinued hormonal preparations?
- Get blood values tested: TSH, complete blood count, ferritin, and possibly Vitamin D – pause biotin beforehand and inform your doctor's office.
- Targeted replenishment instead of broad intake: Only treat proven deficiencies, consume sufficient protein and energy, and avoid crash diets.
- See a dermatologist early: For the hereditary type, time is of the essence. According to guidelines, minoxidil is intended to prevent progression – which is why it is worth not waiting for years.
The VEYT products for this article
VEYT products can compensate for a medically diagnosed nutrient deficiency. They are not a treatment for hair loss and do not replace dermatological therapy. We have consciously chosen to show only the two nutrients here for which the body of evidence suggests a connection with hair loss in women – and no biotin product, because the evidence for that is insufficient.
VEYT Iron Vitality Core
Iron bisglycinate tablets in a 500-count supply. Suitable if a low ferritin value has been medically confirmed and supplementation is recommended. Do not take iron without a blood test.
View VEYT Iron Vitality Core →
VEYT Lumina D3 K2
Vegan drops with 1,000 I.U. Vitamin D3 and Vitamin K2 (all-trans MK-7) according to the product label. Useful for correcting a measured Vitamin D deficiency – not as a hair growth agent.
View VEYT Lumina D3 K2 →Dietary supplements do not replace a balanced diet or medical treatment. In cases of pregnancy, breastfeeding, illness, or regular medication intake, please consult a doctor beforehand.
Expert Perspectives & Protocol Breakdown
Prof. Ulrike Blume-Peytavi (Charité – Universitätsmedizin Berlin)
What she represents: The dermatologist at the Charité is an author of the European S3 guideline on androgenetic alopecia. The guideline clearly focuses on topical minoxidil for women and explicitly does not recommend dietary supplements due to a lack of data.
→ Sources: Charité – Prof. Dr. med. Ulrike Blume-Peytavi · S3 guideline (2018)
Prof. Rodney Sinclair (Dermatologist, Melbourne)
What he represents: Sinclair is one of the researchers who has documented both the prevalence of female hair loss in the population and investigated low-dose oral minoxidil in women. His study with Ramos shows the tablet as an equivalent alternative to the solution – not as a superior therapy.
→ Sources: Gan & Sinclair (2005) · Ramos, Sinclair et al. (2020)
Dr. Eric Berg (Chiropractor, Nutrition Author)
What he recommends: On his website, Berg cites PCOS, thyroid disorders, menopause, stress, and deficiencies in Vitamin D, B vitamins, iron, and zinc as causes for hair loss in women, among others. For solutions, he recommends stress reduction, his low-carb "Healthy Keto" diet, nutrient-rich foods, and scalp massages.
→ Expert source: Dr. Eric Berg – Top Causes of Hair Loss and Natural Solutions
Dr. Josh Axe (Nutrition and Natural Health Author)
What he recommends: Axe lists a wide range of natural remedies, including rosemary oil, biotin, zinc, iron, saw palmetto, pumpkin seed oil, fish oil, and ashwagandha. He describes rosemary oil as apparently similarly effective to minoxidil, citing the study by Panahi et al.
→ Expert source: Dr. Josh Axe – How to Stop Hair Loss: Best Foods, Supplements and Tips
Where They Differ
All four agree that hair loss in women often has multiple causes and that the thyroid, hormones, and nutrient status can play a role. The difference lies in the weighting: the guideline surrounding Blume-Peytavi and the studies by Sinclair focus on medical diagnosis and minoxidil. Berg and Axe rely more heavily on nutrition and natural remedies. Axe's statement regarding rosemary oil is based on a study that examined only men.
What the Evidence Says
Minoxidil is the most strongly supported treatment. For iron and Vitamin D, there are consistent associations with hair loss – resulting in a test-and-replenish approach, not blanket supplementation. For biotin in healthy individuals, rosemary oil in women, saw palmetto, and a low-carb diet as hair therapy, reliable studies in women are lacking. The approaches of Berg and Axe should therefore be classified as expert opinions, not clinically validated treatments.
What one should not declare as a "hair solution" for now
"High-dose biotin makes hair grow"
Not proven without a deficiency – and a risk for false laboratory results when taken in high doses.
"Rosemary oil works like minoxidil"
The study examined men and the weaker 2% solution. For women, the question remains open.
"Hair loss is always a nutrient deficiency"
The most common type is hereditary. The part can become thinner even with perfect blood values.
"More supplements, more hair"
The S3 guideline cannot issue a recommendation for dietary supplements. Iron without a deficiency can even be harmful.
Conclusion
Hair loss in women deserves a real diagnosis instead of a shelf full of hair vitamins. First, recognize the pattern, then have your thyroid, ferritin, and Vitamin D levels checked, and specifically correct any proven deficiencies.
For the hereditary type, minoxidil is the best-supported option. Everything else is a supplement, not a substitute.
Frequently asked questions about hair loss in women
How many hairs per day is normal for women to lose?
A certain amount of daily hair loss is normal because a portion of the hair is always in the resting phase – around 15%, according to StatPearls. It becomes noticeable when suddenly significantly more hair falls out or the part becomes visibly wider.
Which deficiency causes hair loss in women?
The best-supported connection is with low ferritin, meaning depleted iron stores. A Vitamin D deficiency also occurs more frequently in affected individuals. Whether the deficiency is the cause can only be determined on a case-by-case basis.
Which blood values should I have tested for hair loss?
TSH, a complete blood count, ferritin and other iron markers, and if necessary, Vitamin D are useful. In cases of menstrual irregularities or acne, hormonal values may be added.
Does biotin help with hair loss in women?
Only in cases of a true biotin deficiency, which is rare. A systematic review from 2024 found no proven benefit in healthy individuals. High-dose biotin can also distort laboratory values.
What really helps with hereditary hair loss in women?
Topical minoxidil has the strongest evidence and the strongest guideline recommendation. In cases of signs of androgen excess, antiandrogens may be considered; oral minoxidil is an off-label option under medical supervision.
Does hair grow back after telogen effluvium?
Usually, yes. Acute telogen effluvium generally lasts less than six months. However, it takes patience until regrowth becomes visible.
Does rosemary oil help with hair loss?
The well-known comparative study with minoxidil 2% was performed only on men. Corresponding data for women is lacking, therefore rosemary oil is not a proven substitute for minoxidil.
When should I see a doctor for hair loss?
In cases of sudden or patchy hair loss, itching, redness, or flaking of the scalp, accompanying menstrual irregularities, or if the part becomes visibly wider over months.
References & Scientific Citations
- Gan DC, Sinclair RD – Prevalence of male and female pattern hair loss in Maryborough (2005)
- Hughes EC, Syed HA, Saleh D – Telogen Effluvium, StatPearls (2024)
- Treister-Goltzman Y et al. – Iron Deficiency and Nonscarring Alopecia in Women, Skin Appendage Disorders (2022)
- Suchonwanit P et al. – Vitamin D deficiency in alopecia, Frontiers in Nutrition (2024)
- Yelich E et al. – Biotin for Hair Loss: Teasing Out the Evidence, JCAD (2024)
- FDA – Biotin Interference with Troponin Lab Tests (2022)
- Cochrane – Measures for female hair loss, CD007628 (2016)
- Kanti V et al. – S3 guideline for androgenetic alopecia, JEADV (2018)
- Ramos PM, Sinclair RD et al. – Oral vs. topical minoxidil in FPHL, JAAD (2020)
- Vañó-Galván S et al. – Safety of low-dose oral minoxidil, 1404 patients, JAAD (2021)
- Deutsche Apotheker Zeitung – Oral Minoxidil for hair loss (2025)
- Aleissa M – Oral Spironolactone in FPHL, Cureus (2023)
- Panahi Y et al. – Rosemary oil vs minoxidil 2%, Skinmed (2015)
- Charité – Prof. Dr. med. Ulrike Blume-Peytavi
- Dr. Eric Berg – Top Causes of Hair Loss and Natural Solutions
- Dr. Josh Axe – How to Stop Hair Loss
Source transparency: The mentioned doctors and authors are used as perspective sources. Statements on diagnosis and treatment are primarily classified based on guidelines, systematic reviews, meta-analyses, and randomized studies. Expert opinion, observational data, and clinical efficacy evidence are not equated. This article was written independently; figures were verified against the linked original sources.
